---
figid: PMC5713305__ijms-18-02336-g002
figtitle: Nuclear factor erythroid 2-related factor 2 (Nrf2) regulatory pathway
organisms:
- NA
pmcid: PMC5713305
filename: ijms-18-02336-g002.jpg
figlink: /pmc/articles/PMC5713305/figure/ijms-18-02336-f002/
number: F2
caption: Nuclear factor erythroid 2-related factor 2 (Nrf2) regulatory pathway. (A)
  Structural Nrf2-ECH homology (Neh) 1–7 domains of human Nrf2 protein; (B) Keap1-dependent
  and Keap1-independent mediated Nrf2 regulatory pathway. Under basal condition, Nrf2
  undergoes Keap-1 mediated polyubiquitination and degradation in the proteasomes.
  Exposure of cells to oxidative stress triggers a conformational change in Keap1
  through modification of its cysteine residues, which results in the release of Nrf2
  from Keap1. Apart from Keap1-dependent pathway, Nrf2 activation is also mediated
  by p38, PKC, PI3K/AKT, MAPK/ERK and JNK via phosphorylation of the serine or threonine
  residues of Nrf2. Stabilized cytosolic Nrf2 are translocated into the nucleus whereby
  they form heterodimers with small Maf protein and activate cell defense genes. Keap1
  indicates Kelch-like ECH-associated protein 1; RXRα, retinoid X receptor α; β-TrCP,
  β-transducin repeat-containing protein; Maf, musculoaponeurotic fibrosarcoma; ARE,
  antioxidant response element; CHD 6, chromo-ATPase/helicase DNA-binding protein
  6; Ub, ubiquitin; PKC; protein kinase C; PI3K/AKT, phosphatidylinositol-3-kinase;
  MAPK, mitogen-activated protein kinase cascades; ERK, extracellular-signal-regulated
  kinase; JNK, c-Jun N-terminal kinase; NQO1, NADPH quinine oxidoreductase 1; GSTs,
  glutathione S-transferases; AKRs, aldo-keto reductases; GPX, glutathione peroxidase;
  GCLC, glutamate-cysteine ligase; GCLM, glutamate-cysteine ligase modifier subunit;
  GR, glutathione reductase; SOD, superoxide dismutase; TXN1, thioredoxin; TXNR, thioredoxin
  reductase 1, PRDX1, peroxiredoxin 1; HMOX1, heme oxygenase (decycling) 1; FECH,
  ferrochelatase, and; MRP, multidrug resistance-associated proteins.
papertitle: 'Oxidative Stress in Cardiovascular Diseases: Involvement of Nrf2 Antioxidant
  Redox Signaling in Macrophage Foam Cells Formation.'
reftext: Bee Kee Ooi, et al. Int J Mol Sci. 2017 Nov;18(11):2336.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7724962
figid_alias: PMC5713305__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC5713305__F2
ndex: bdcd1dac-df2d-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5713305__ijms-18-02336-g002.html
  '@type': Dataset
  description: Nuclear factor erythroid 2-related factor 2 (Nrf2) regulatory pathway.
    (A) Structural Nrf2-ECH homology (Neh) 1–7 domains of human Nrf2 protein; (B)
    Keap1-dependent and Keap1-independent mediated Nrf2 regulatory pathway. Under
    basal condition, Nrf2 undergoes Keap-1 mediated polyubiquitination and degradation
    in the proteasomes. Exposure of cells to oxidative stress triggers a conformational
    change in Keap1 through modification of its cysteine residues, which results in
    the release of Nrf2 from Keap1. Apart from Keap1-dependent pathway, Nrf2 activation
    is also mediated by p38, PKC, PI3K/AKT, MAPK/ERK and JNK via phosphorylation of
    the serine or threonine residues of Nrf2. Stabilized cytosolic Nrf2 are translocated
    into the nucleus whereby they form heterodimers with small Maf protein and activate
    cell defense genes. Keap1 indicates Kelch-like ECH-associated protein 1; RXRα,
    retinoid X receptor α; β-TrCP, β-transducin repeat-containing protein; Maf, musculoaponeurotic
    fibrosarcoma; ARE, antioxidant response element; CHD 6, chromo-ATPase/helicase
    DNA-binding protein 6; Ub, ubiquitin; PKC; protein kinase C; PI3K/AKT, phosphatidylinositol-3-kinase;
    MAPK, mitogen-activated protein kinase cascades; ERK, extracellular-signal-regulated
    kinase; JNK, c-Jun N-terminal kinase; NQO1, NADPH quinine oxidoreductase 1; GSTs,
    glutathione S-transferases; AKRs, aldo-keto reductases; GPX, glutathione peroxidase;
    GCLC, glutamate-cysteine ligase; GCLM, glutamate-cysteine ligase modifier subunit;
    GR, glutathione reductase; SOD, superoxide dismutase; TXN1, thioredoxin; TXNR,
    thioredoxin reductase 1, PRDX1, peroxiredoxin 1; HMOX1, heme oxygenase (decycling)
    1; FECH, ferrochelatase, and; MRP, multidrug resistance-associated proteins.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - maf-S
  - Maf1
  - slmb
  - cui
  - Cul3
  - Cys
  - mmy
  - Csp
  - dlg1
  - Dlg5
  - dlg2
  - Keap1
  - GstS1
  - Gclc
  - gr
  - PHGPx
  - Gclm
  - Cat
  - so
  - Sod2
  - Sod1
  - Jafrac1
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - FeCH
  - MRP
  - Mhc
  - RNaseMRP:RNA
  - l(1)2Fc
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Erk7
  - rl
  - MKP-4
  - bsk
  - cnc
  - MAF
  - MAFA
  - MAFB
  - MAFF
  - MAFG
  - MAFK
  - RXRA
  - BTRC
  - NEIL2
  - CUL1
  - CUL2
  - CUL3
  - CUL4A
  - CUL4B
  - CUL5
  - CUL7
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - KEAP1
  - HPGDS
  - GCLC
  - GPX1
  - GPX2
  - GPX3
  - GPX4
  - GPX5
  - GPX6
  - GPX7
  - GPX8
  - GCLM
  - TXN
  - SOD1
  - SOD2
  - SOD3
  - TXNRD1
  - PRDX1
  - FECH
  - HMOX1
  - ABCC1
  - MARCKSL1
  - WLS
  - CRK
  - MAPK14
  - MAPK1
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK3
  - MAPK8
  - MAPK9
  - MAPK10
  - GABPA
  - NFE2L2
  - Cys
  - Heme
  - Cancer
---
